|
| ||
|
|
||
Calcium Phosphate Cement (calcium + phosphate_cement)
Selected AbstractsControl of Crystallinity of Hydrated Products in a Calcium Phosphate CementJOURNAL OF THE AMERICAN CERAMIC SOCIETY, Issue 4 2009Tao Yu A novel calcium phosphate cement (CPC) was prepared by dry-mechanochemical rout in this work. With the different crystallinity, the CPC showed the different degradation ratio after setting. The degradation ratio of CPC was characterized by the calcium ion-dissolving ratio in deionized water after different soaking time. With the increment of crystallinity, the setting times of CPC were prolonged, and the different mechanical property of CPC were obtained. This novel CPC was supposed to match the new bone ingrowth in vivo and have the potential application in orthopedic surgery for filling non-load-bearing bone defects. [source] Reinforcement of Calcium Phosphate Cement by Bio-Mineralized Carbon NanotubeJOURNAL OF THE AMERICAN CERAMIC SOCIETY, Issue 3 2007Xiupeng Wang Bio-mineralized carbon natotubes (CNTs) were prepared by soaking carboxyl functionalized CNTs in a simulating body fluid (SBF). A uniform hydroxyapatite layer was precipitated on the outer walls of CNTs after 7 days of soaking. The results showed that, by addition of the as-received CNTs and bio-mineralized CNTs, the compressive strength of the calcium phosphate cement (CPC) increased by 24% and 120%, respectively. The modified interfacial bonding between the bio-mineralized CNTs and CPC accounted for the significant improvement in the mechanical property by addition of the bio-mineralized CNTs as compared with the as-received CNTs. [source] Fiber Reinforced Calcium Phosphate CementARTIFICIAL ORGANS, Issue 3 2000Luís Alberto Dos Santos Abstract: The term calcium phosphate cement was introduced by Gruninger et al. (1). This type of cement can be prepared by reacting a calcium phosphate salt with an aqueous solution, which causes it to set by the crossing of the precipitated crystals. These cements offer a series of advantages that allow their use as grafts and substitutes of damaged parts of the bone system. However, these cements have low mechanical strength compared to human bones. This work studied the influence of the use of polyamide fibers in the mechanical properties of a calcium phosphate cement based on ,-tricalcium phosphate as well as the mechanisms involved in the increase of mechanical strength. The results demonstrate the feasibility of the use of polymeric fibers to increase mechanical strength and the need for coupling agents for the effective performance of the fibers as reinforcement in these materials. [source] Calcium phosphate cement reinforced by polypeptide copolymersJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2006Jiaping Lin Abstract Water-based calcium phosphate with bone repairing capability was reinforced by polypeptide graft copolymers and micelles that were formed by polypeptide copolymers. The mechanical studies showed that the compression strength and fracture energy of the calcium phosphate cement (CPC)/polypeptide composites are appreciably higher than those of CPC. The molecular structure of the polypeptide graft copolymers and the association form of the polypeptide copolymers exhibit a marked effect on the mechanical properties of CPC/polypeptide composites. The polypeptide copolymers with more hydrophilic side chains and with core-shell micelle forms have more effective reinforcement effect. The morphological studies based on the scanning electron microscope (SEM) observations revealed that both polypeptide graft copolymers and polypeptide copolymer micelles are well dispersed in CPC matrix. According to the obtained experimental results, reinforcement mechanism was suggested. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006 [source] In vivo release of the antimicrobial peptide hLF1-11 from calcium phosphate cement,JOURNAL OF ORTHOPAEDIC RESEARCH, Issue 4 2008Hein P. Stallmann Abstract We studied the release of human lactoferrin 1-11 (hLF1-11), a potent antimicrobial peptide, in an animal model. Calcium phosphate cement with 50 mg/g hLF1-11 was injected into the femoral canal of 12 rabbits. One, 3, and 7 days later, four animals were terminated, and the femora excised. Sections of bone and cement were removed for histological analysis. We used liquid chromatography-mass spectrometry/mass spectrometry for semiquantitative determination of the hLF1-11 concentration. Blood samples were drawn for leukocyte count and differentiation to identify a potential immunomodulating effect of hLF1-11. After an initial burst release, the hLF1-11 concentration in cement and bone decreased steadily. This in vivo release profile is consistent with earlier in vitro studies. Tissue ingrowth into the cement, without signs of inflammation or necrosis, was observed. Leukocytosis or a shift in leukocyte differentiation did not occur. The carrier released over 99% of the hLF1-11, resulting in peak concentrations at the cement,bone interface. This indicates that hLF1-11 could become a valuable prophylactic agent in osteomyelitis treatment. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:531,538, 2008 [source] Self-hardening calcium phosphate composite scaffold for bone tissue engineering,JOURNAL OF ORTHOPAEDIC RESEARCH, Issue 3 2004Hockin H. K. Xu Abstract Calcium phosphate cement (CPC) sets in situ to form solid hydroxyapatite, can conform to complex cavity shapes without machining, has excellent osteoconductivity, and is able to be resorbed and replaced by new bone. Therefore, CPC is promising for craniofacial and orthopaedic repairs. However, its low strength and lack of macroporosity limit its use. This study investigated CPC reinforcement with absorbable fibers, the effects of fiber volume fraction on mechanical properties and macroporosity, and the cytotoxicity of CPC,fiber composite. The rationale was that large-diameter absorbable fibers would initially strengthen the CPC graft, then dissolve to form long cylindrical macropores for colonization by osteoblasts. Flexural strength, work-of-fracture (toughness), and elastic modulus were measured vs. fiber volume fraction from 0% (CPC Control without fibers) to 60%. Cell culture was performed with osteoblast-like cells, and cell viability was quantified using an enzymatic assay. Flexural strength (mean ± SD; n == 6) of CPC with 60% fibers was 13.5 ± 4.4 MPa, three times higher than 3.9 ± 0.5 MPa of CPC Control. Work-of-fracture was increased by 182 times. Long cylindrical macropores 293 ± 46 ,m in diameter were created in CPC after fiber dissolution, and the CPC,fiber scaffold reached a macroporosity of 55% and a total porosity of 81%. The new CPC,fiber formulation supported cell adhesion, proliferation and viability. The method of using large-diameter absorbable fibers in bone graft for mechanical properties and formation of long cylindrical macropores for bone ingrowth may be applicable to other tissue engineering materials. Published by Elsevier Ltd. on behalf of Orthopuedic Research Society. © 2003 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved. [source] A novel silicate-doped calcium-based composite dental pulp capping agentASIA-PACIFIC JOURNAL OF CHEMICAL ENGINEERING, Issue 5 2009Fangping Chen Abstract The development of a dental pulp capping agent (DPCA) requires suitable setting time, acceptable compressive strength, favorable bioactivity, and to facilitate cementum tissue regeneration. Calcium phosphate cement (CPC) is widely used for its self-setting, biodegradability, biocompatibility, and formability. However, a relative low strength and lack of bioactivity have limited its application. Herein, dicalcium silicate (Ca2SiO4, C2S) was introduced into CPC to prepare a novel silicate-doped CPC/C2S composite DPCA by self-setting in situ and its setting time, compressive strength, bioactivity, and biomineralization behaviors were investigated. The results indicated that the mechanical strength and setting time of DPCA were higher than those of pure CPC. C2S transformed into a CSH gel without disturbing the hydration of DPCA after soaking in SBF for 5 days. Moreover, much more bone-like hydroxyapatite layers were formed, and DPCA exhibited higher bioactivity mainly in virtue of the rapid formation of CSH. DPCA with 15 wt% C2S, suggested to be the optimized composite, exhibited significantly improved bioactivity and high compressive strength, indicating that DPCA with 15 wt % C2S might have a significant pulp capping therapy advantage over the pure CPC. Copyright © 2009 Curtin University of Technology and John Wiley & Sons, Ltd. [source] Improvement of Mechanical Properties of Self Setting Calcium Phosphate Bone Cements Mixed With Different Metal OxidesMATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK, Issue 12 2003U. Gbureck Calciumphosphat Zemente; Metalloxide; Mechanische Eigenschaften Abstract Calcium phosphate cements (CPC), based on multicomponent powder mixtures of calcium orthophosphates with medium particle sizes in the region of 1 - 20 ,m, set isothermally in an aqueous environment to form hydroxyapatite (HA). HA cement reactants include tetracalcium phosphate (TTCP), tricalcium phosphate (TCP), dicalcium phosphate anhydrate (DCPA), dicalcium phosphate dihydrate (DCPD), monocalcium phosphate (MCPA) or octacalcium phosphate (OCP). The aim of this study was to improve the mechanical performance of TTCP / DCPA cement by adding several metal oxides to tetracalcium phosphate during the fabrication process. Cements based on tetracalcium phosphate mixed with silica or titanium oxide showed significant increases in compressive strength, approximately 80 - 100 MPa, whilst no change in the mechanical behavior of CPC was observed if zirconia was added. X-ray diffraction measurement confirmed the setting reaction of doped cements was similar to that of pure CPC. Low crystalline HA was found to be the main constituant of set cement; additional phases, such as calcium titanate or calcium zirconate, were not involved in the reaction. A mechanical reinforcement effect was thought to result from changes in the thermodynamic or kinetic solubilities of doped tetracalcium phosphates, this would lead to slower HA crystal formation and a more cross-linked cement structure. Verbesserung der mechanischen Eigenschaften von Calciumphosphat-Zementen durch Modifikation mit verschiedenen Metalloxiden Calciumphosphat-Zemente, CPC, bestehen aus Pulvermischungen verschiedener Calcium orthophophate, beispielsweise Tetracalciumphosphat (TTCP), Tricalciumphosphat (TCP), Dicalciumphosphatanhydrid (DCPA), Dicalciumphosphatdihydrat (DCPD), Monocalcium phosphatanhydrid (MCPA) oder Octacalciumphosphat (OCP) mit durchschnittlichen Partikelgrößen im Bereich von 1 , 20 ,m. Die Zemente binden in wässriger Umgebung isotherm zu Hydroxylapatit ab. Das Ziel dieser Arbeit war die Verbesserung materialspezifischer Eigenschaften , wie die mechanische Festigkeit - eines TTCP / DCPA-Zementes durch die Verwendung von Metalloxiden im Syntheseprozess von Tetracalciumphosphat. Zemente, die aus mit Silicium- oder Titandioxid versetzten Tetracalciumphosphaten hergestellt wurden, zeigten eine deutliche Steigerung der Druckfestigkeit auf Werte von 80 , 100 MPa, während im Falle von Zirkoniumdioxid keine Änderung der mechanischen Stabilität erreicht werden konnte. Röntgendiffraktometrische Untersuchungen ergaben, dass die Abbindereaktion dieser Zemente ähnlich der eines reinen TTCP / DCPA-Zements verläuft. Jeweiliges Hauptprodukt war niedrigkristalliner Hydroxylapatit, die im Herstellungsprozess von Tetracalciumphosphat entstandenen Nebenprodukte Calciumtitanat bzw. ,zirkonat waren nicht an der Abbindereaktion beteiligt. Ein Grund für die Steigerung der mechanischen Stabilität ist offensichtlich die Veränderung der kinetischen und thermodynamischen Löslichkeit der synthetisierten Tetracalciumphosphate, die zu einer langsameren Abbindereaktion und somit einer besseren Vernetzung in der Hydroxylapatitstruktur führt. [source] The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: Acetic acid versus citric acidJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 1 2008Saeed Hesaraki Abstract In the present study, macroporous calcium phosphate cements (CPCs) were prepared using a porogen; that is, the gas-foaming technique. The objective was to investigate the influence of the acidic component of the porogen (acetic acid versus citric acid) on several properties of a specified CPC. In all of the cements prepared, the basic component of the porogen was the same, namely, NaHCO3, and it was added to the powder phase of the cement, while the acidic component of the porogen was dissolved in the liquid phase of the cement. The cements were characterized in terms of initial setting time, porosity, crystallinity, injectability and compressive strength. Also, XRD, FTIR, and SEM techniques were employed to evaluate the phase composition, the chemical groups and the morphological aspects of the porous cements during setting. It was found that the presence of a porogen in a CPC led to significant decreases in both its initial setting time and compressive strength. A CPC made using acetic acid contained a larger amount of the apatite phase but was significantly less injectable and less porous than when citric acid was used. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008 [source] Influence of anti-washout agents on the rheological properties and injectability of a calcium phosphate cementJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2007Xiupeng Wang Abstract Anti-washout-type calcium phosphate cement (aw-CPC) was prepared by introducing chitosan, sodium alginate, or modified starch into the powder phase of CPC, respectively. The results showed that these cements cannot be washed out and set within approximately 10,30 min even if the pastes were immersed in distilled water immediately and were shaken in a shaker after mixing and moulding. To our knowledge, it is the first report about the influence of the content of these anti-washout additives on the rheological properties and injectability of the cement. Moreover, novel approach of yield stress measurement was used to evaluate the injectability of the pastes. A modified starch was originally used as anti-washout agent for CPC. This study provided a convenient way to use the injectable CPC with good anti-washout performance when the paste was exposed to blood. The aw-CPC had potential prospects for the wider applications in surgery such as orthopaedics, oral, and maxillofacial surgery. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006 [source] Calcium phosphate cement reinforced by polypeptide copolymersJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2006Jiaping Lin Abstract Water-based calcium phosphate with bone repairing capability was reinforced by polypeptide graft copolymers and micelles that were formed by polypeptide copolymers. The mechanical studies showed that the compression strength and fracture energy of the calcium phosphate cement (CPC)/polypeptide composites are appreciably higher than those of CPC. The molecular structure of the polypeptide graft copolymers and the association form of the polypeptide copolymers exhibit a marked effect on the mechanical properties of CPC/polypeptide composites. The polypeptide copolymers with more hydrophilic side chains and with core-shell micelle forms have more effective reinforcement effect. The morphological studies based on the scanning electron microscope (SEM) observations revealed that both polypeptide graft copolymers and polypeptide copolymer micelles are well dispersed in CPC matrix. According to the obtained experimental results, reinforcement mechanism was suggested. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006 [source] Effect of vertebroplasty filler materials on viability and gene expression of human nucleus pulposus cellsJOURNAL OF ORTHOPAEDIC RESEARCH, Issue 5 2008Áron Lazáry Abstract Consequences of intradiscal cement leakage,often occurring after vertebral cement augmentation for the treatment of vertebral compression fractures,are still unknown. In this study, we have investigated the influences of vertebroplasty filler materials (polymethylmethacrylate-, calcium phosphate- and calcium sulfate-based bone cement) on isolated nucleus pulposus cells. Cell viability of cultured human nucleus pulposus cells were measured after treatment with vertebroplasty filler materials. Gene expression profile of selected genes was determined with quantitative real-time PCR. The widely used polymethylmethacrylate and calcium phosphate cement significantly decreased cell number in a dose- and time-dependent manner while calcium sulfate cement affected cell viability less. Expression of genes involved in matrix metabolism of nucleus pulposus,aggrecan, collagens, small proteoglycans,as well as important transcription factors have also significantly changed due to treatment (e.g., 2.5-fold decrease in aggrecan expression was determined in cultures due to polymethylmethacrylate treatment). Our results suggest that vertebroplasty filler materials,depending on the type of applied material,can accelerate the degeneration of nucleus pulposus cells resulting in a less flexible disc in case of intradiscal cement leakage. This process may increase the risk of a subsequent new vertebral fracture, the main complication of vertebral augmentation. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:601,607, 2008 [source] In vivo release of the antimicrobial peptide hLF1-11 from calcium phosphate cement,JOURNAL OF ORTHOPAEDIC RESEARCH, Issue 4 2008Hein P. Stallmann Abstract We studied the release of human lactoferrin 1-11 (hLF1-11), a potent antimicrobial peptide, in an animal model. Calcium phosphate cement with 50 mg/g hLF1-11 was injected into the femoral canal of 12 rabbits. One, 3, and 7 days later, four animals were terminated, and the femora excised. Sections of bone and cement were removed for histological analysis. We used liquid chromatography-mass spectrometry/mass spectrometry for semiquantitative determination of the hLF1-11 concentration. Blood samples were drawn for leukocyte count and differentiation to identify a potential immunomodulating effect of hLF1-11. After an initial burst release, the hLF1-11 concentration in cement and bone decreased steadily. This in vivo release profile is consistent with earlier in vitro studies. Tissue ingrowth into the cement, without signs of inflammation or necrosis, was observed. Leukocytosis or a shift in leukocyte differentiation did not occur. The carrier released over 99% of the hLF1-11, resulting in peak concentrations at the cement,bone interface. This indicates that hLF1-11 could become a valuable prophylactic agent in osteomyelitis treatment. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:531,538, 2008 [source] Control of Crystallinity of Hydrated Products in a Calcium Phosphate CementJOURNAL OF THE AMERICAN CERAMIC SOCIETY, Issue 4 2009Tao Yu A novel calcium phosphate cement (CPC) was prepared by dry-mechanochemical rout in this work. With the different crystallinity, the CPC showed the different degradation ratio after setting. The degradation ratio of CPC was characterized by the calcium ion-dissolving ratio in deionized water after different soaking time. With the increment of crystallinity, the setting times of CPC were prolonged, and the different mechanical property of CPC were obtained. This novel CPC was supposed to match the new bone ingrowth in vivo and have the potential application in orthopedic surgery for filling non-load-bearing bone defects. [source] Reinforcement of Calcium Phosphate Cement by Bio-Mineralized Carbon NanotubeJOURNAL OF THE AMERICAN CERAMIC SOCIETY, Issue 3 2007Xiupeng Wang Bio-mineralized carbon natotubes (CNTs) were prepared by soaking carboxyl functionalized CNTs in a simulating body fluid (SBF). A uniform hydroxyapatite layer was precipitated on the outer walls of CNTs after 7 days of soaking. The results showed that, by addition of the as-received CNTs and bio-mineralized CNTs, the compressive strength of the calcium phosphate cement (CPC) increased by 24% and 120%, respectively. The modified interfacial bonding between the bio-mineralized CNTs and CPC accounted for the significant improvement in the mechanical property by addition of the bio-mineralized CNTs as compared with the as-received CNTs. [source] Fiber Reinforced Calcium Phosphate CementARTIFICIAL ORGANS, Issue 3 2000Luís Alberto Dos Santos Abstract: The term calcium phosphate cement was introduced by Gruninger et al. (1). This type of cement can be prepared by reacting a calcium phosphate salt with an aqueous solution, which causes it to set by the crossing of the precipitated crystals. These cements offer a series of advantages that allow their use as grafts and substitutes of damaged parts of the bone system. However, these cements have low mechanical strength compared to human bones. This work studied the influence of the use of polyamide fibers in the mechanical properties of a calcium phosphate cement based on ,-tricalcium phosphate as well as the mechanisms involved in the increase of mechanical strength. The results demonstrate the feasibility of the use of polymeric fibers to increase mechanical strength and the need for coupling agents for the effective performance of the fibers as reinforcement in these materials. [source] Injectable calcium phosphate cement as a graft material for maxillary sinus augmentation: an experimental pilot studyCLINICAL ORAL IMPLANTS RESEARCH, Issue 6 2008Ali Aral Abstract Objectives: The aim of the present study was to evaluate the efficiency of injectable CaP cement as a graft material around dental implants in the maxillary sinus augmentation procedure. Material and methods: Bilateral sinus augmentation process was carried out in three sheep and two implants were inserted during the same session. Out of a total of 12 installed implants, eight belonged to the so-called experimental group. In the experimental group, injectable CaP cement was used as augmentation material while autologous bone served as control. Results: Histological examination revealed that newly formed bone surrounded the cement completely without an intervening fibrous tissue layer. Following a healing period of 12 weeks, mean bone-to-implant contact (BIC) values in the experimental and control groups were 36±5 and 37±3, respectively. The percentage of BIC was comparable with other experimental sinus augmentation studies. Further, it appeared that the thickness of the cortical bone that covered the outer surface of the maxillary sinus was <2,3 mm, which affected the primary stability of the implants negatively. Conclusion: CaP cement is indeed effective to stimulate bone formation in the sinus elevation procedure. Nevertheless, additional improvements in the cement composition are required to allow final clinical utilization of the material. [source] The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substituteCLINICAL ORAL IMPLANTS RESEARCH, Issue 6 2004An experimental study in rats Abstract Objectives: Autogeneous bone grafting is regarded to be the golden standard for onlay grafts, but it requires a harvesting procedure and the remodeling pattern over time is unpredictable. New materials are constantly being sought to overcome these problems. An in vivo experiment was carried out to evaluate whether (1) porous calcium phosphate cement is a suitable biomaterial for onlay bone grafting, and (2) the addition of transforming growth factor beta 1 (TGF-,1) accelerates de novo bone formation inside the cement porosity. Material and methods: A carrier of porous calcium phosphate cement (Calcibon®) was designed and 16 rats received one preshaped implant each. In 8 out of 16 implants 0.75 ,g TGF-,1 was applied. The animals were killed after 4 weeks and the characteristics of tissue ingrowth into the onlay graft were evaluated. Results: Histologic and quantitative histomorphometrical measurements demonstrated osteoid-like tissue formation in both experimental groups. The addition of TGF-,1 did not induce significantly more osteoid-like tissue formation. On the other hand, in TGF-,-loaded implants, a higher number of pores contained an inflammatory infiltrate. Conclusion: This study indicated that porous calcium phosphate cement is a promising material for clinical situations where bone formation has to be supported. Résumé La greffe osseuse autogène est considérée comme la meilleure technique actuelle pour les greffons onlay mais elle requiert un processus de prélevement et le remodelage qui s'en suit est imprévisible. De nouveaux matériaux sont donc constamment recherchés. Cette étude in vitro a essayé d'évaluer si 1) le cément phosphate calcium poreux était un biomatériel favorable pour le greffage osseux onlay, 2) si l'addition de TGF-,1 accélérait la néoformation osseuse à l'intérieur de la porosité du cément. Un porteur de cément phosphate calcium poreux (Calcibon®) a été fabriqué et seize rats ont reçu chacun un implant prédécoupé. Au niveau de huit des seize implants 0,75 ,g de TGF ,1 a été appliqué. Les animaux ont été euthanasiés après quatre semaines et les caractéristiques de la croissance interne tissulaire dans le greffon onlay ont étéévaluées. Les mesures histologiques et histomorphométriques quantitatives ont démontré une formation tissulaire semblable à l'ostéogénie dans les deux groupes expérimentaux. L'addition de TGF-ß1 n'induisait pas plus de formation tissulaire ressemblant à celle d'ostéogénie. D'un autre côté, dans les implants chargés de TGF-,1, un nombre plus important de pores contenaient un infiltrat inflammatoire. Cette étude indique que le cément phosphate calcium poreux est un matériau prometteur pour les situations cliniques dans lesquelles la formation osseuse doit être améliorée. Zusammenfassung Ziel: Die Transplantation von autologem Knochen wird heute als Goldstandard für die Onlay-Transplantate betrachtet. Es braucht dazu aber einen zusätzlichen Eingriff für die Entnahme und eine Prognose bezüglich der anschliessenden Remodellationsvorgänge sind kaum möglich. Man sucht ständig nach neuen Produkten, um diese Probleme zu überwinden. Man führte eine in vivo Studie durch und untersucht, ob (1) ein poröser Kalziumphosphatzement ein brauchbares Biomaterial für ein Onlay-Transplantat ist, und (2) der Zusatz von TGF-,1 die Neubildung von Knochen in den Porositäten des Zementes positiv beeinflusst. Material und Methode: Man entwickelte einen Trägerzement aus porösem Kalziumphosphat (Calcibon®) und 16 Ratten erhielten je ein vorgeformtes Implantat eingesetzt. Bei 8 der 16 Implantate fügte man zusätzlich 0.75 ,g TGF-,1 dazu. Vier Wochen später opferte man die Tiere und konnte nun die Charakteristika des in die Implantate einwachsenden Gewebes untersuchen. Resultate: Die histologischen und quantitativen histomorphometrischen Messungen zeigten in beiden experimentellen Gruppen osteoidähnliche Gewebsbildungen. Der Zusatz von TGF-,1 bewirkte keine signifikante Zunahme dieser osteoidähnlichen Gewebsbildungen. Die mit TGF-,1 durchsetzten Implantate enthielten aber mehr mit entzündlichem Infiltrat angefüllte Poren. Zusammenfassung: Diese Arbeit zeigte uns, dass ein poröser Kalziumphosphatzement bei klinischen Situationen, wo die Knochenbildung unterstützt werden muss, ein erfolgsversprechendes Material ist. Resumen Objetivos: El injerto de hueso autógeno está considerado como el estándar de oro para injertos superpuestos, pero requiere un procedimiento de recolección y el patrón de remodelado a lo largo del tiempo es impredecible. Constantemente se están buscando materiales nuevos para superar estos problemas. Se llevó a cabo un experimento in vivo para evaluar si (1) el cemento de fosfato cálcico poroso es un biomaterial apropiado para injerto óseo superpuesto, y (2) la adición de TGF-,1 acelera la formación de hueso de novo dentro de la porosidad del cemento. Material y Métodos: Se diseñó un portador de cemento de fosfato cálcico (Calcibon®) y 16 ratas recibieron un implante preformado cada una. En 8 de 16 implantes se aplicaron 0.75 ,g de TGF-,1. Los animales se sacrificaron tras 4 semanas y se evaluaron las características del tejido crecido hacia adentro del injerto superpuesto. Resultados: Las mediciones histológicas e histomorfométricas cuantitativas demostraron formación de tejido tipo osteoide en ambos grupos experimentales. La adición de TGF-,1 no indujo significativamente más formación de tejido tipo osteoide. Por otro lado, en los implantes cargados con TGF-,1, un mayor número de de poros contenían infiltrado inflamatorio. Conclusión: Este estudio indica que el cemento de fosfato cálcico poroso es un material prometedor para situaciones clínicas donde la formación de hueso ha de ser favorecida. [source] Injectable calcium phosphate cement as a filler for bone defects around oral implants: an experimental study in goatsCLINICAL ORAL IMPLANTS RESEARCH, Issue 3 2002Luca Comuzzi Abstract: The aim of this study was to evaluate the clinical applicability and biological behavior of a newly developed injectable calcium phosphate (Ca-P) cement as bone filler for gaps around oral implants. Twenty-four step-like implants, creating gaps of 1 and 2 mm, were inserted into the trabecular bone of the medial femoral condyles of six goats. Four different situations were tested: (1) implant + gaps; (2) implant + gaps, but covered with a polylactic acid membrane; (3) implant + gaps that were filled with Ca-P cement; and (4) implant + gaps that were filled with Ca-P cement and covered with a membrane. All implants were left in place for 12 weeks. Histological and quantitative histomorphometrical measurements demonstrated that implants + gaps had generally poor bone contact at the implant base. Furthermore, fibrous encapsulation was observed in the gap part. In contrast, the presence of a membrane promoted bone ingrowth into the gap and also the bone contact at the implant base. Injection of Ca-P cement resulted in an almost complete filling of the gaps around the implant. The cement surface was completely covered by bone. Active resorption and remodeling of cement particles was observed, suggesting a pattern of slow resorption associated with full replacement with newly formed bone. Additional use of a membrane did not result in adjunctive benefits. Bone-to-implant contact at the implant base was comparable with the implants provided only with a membrane. In conclusion, the Ca-P cement used here showed excellent clinical handling properties combined with a superior bone behavior. On the other hand, the degradation rate of the material was still very slow. This current characteristic can hamper the final clinical applicability of the material as gap filler for periimplant or periodontal defects. Résumé Le but de l'étude présente a été d'évaluer l'application clinique et le comportement biologique d'un nouveau ciment de calcium de phosphate injectable (Ca-P) comme comblement osseux pour les cavités autour des implantes dentaires. Vingt-quatre implants créant des cavités de 1 et 2 mm ont été insérés dans l'os trabéculaire des condyles fémoraux moyens de six chèvres. Quatre situations différentes ont été testées: 1) implant + cavités; 2) implant = cavités recouvertes par une membrane en acide polylactique, 3) implant + cavités comblées par le ciment Ca-P et 4) implant + cavités comblées par le ciment Ca-P et recouvertes par une membrane. Tous les implants ont été laissés in situ pendant douze semaines. Les mesures histologiques et quantitatives histomorphométriques ont démontré que les implants + cavités avaient généralement un contact osseux pauvre au niveau de la base implantaire. De plus, une encapsulation fibreuse était observée dans la partie cavité. Par contre, la présence d'une membrane favorisait la croissance osseuse dans la cavité ainsi que le contact osseux à la base de l'implant. L'injection du cément Ca-P résultait en une réparation quasi complète des cavités autour de l'implant. La surface cémentaire était complètement recouverte d'os. La résorption active et le remodelage des particules de cément étaient observés, ce qui suggérait un système de résorption lente associéà un remplacement complet par de l'os néóformé. L'usage additionnel d'une membrane ne s'accompagnait pas de bénéfice supplémentaire. Le contact os/implant à la base de l'implant était comparable à celui des implants installés seulement avec une membrane. En conclusion, le ciment Ca-P possèdait des propriétés cliniques excellentes combinées à un comportement osseux supérieur. Par contre le taux de dégradation du matériel était toujours très lent. Cette caractéristique pourrait gêner l'application clinique finale de ce matériel en tant que comblement des cavités autour des implants ou dans les lésions parodontales. Zusammenfassung Das Ziel dieser Studie war es, die klinische Anwendbarkeit und das biologische Verhalten eines neu entwickelten injizierbaren Kalziumphosphatzements (Ca-P) als Knochenfüller bei oralen Implantaten auszuwerten. Vierundzwanzig stufenförmige Implantate, welche Defekte von 1 und 2 mm kreieren, wurden in den trabekulären Knochen der medialen femoralen Kondylen von 6 Ziegen eingesetzt. Vier verschiedene Situationen wurden getestet: 1) Implantat + Defekte; 2) Implantat + Defekte, aber bedeckt mit einer Membran aus Polimilchsäure; 3) Implantat + Defekte, welche mit Ca-P-Zement gefüllt wurden; 4) Implantat + Defekte, welche mit Ca-P-Zement gefüllt und mit einer Membran bedeckt wurden. Alle implantate wurden 12 Wochen belassen. Histologische und quantitative histomorphometrische Messungen zeigten, dass Implantate + Defekte generell schlechten Knochenkontakt an der Implantatbasis aufwiesen. Ausserdem wurde eine fibröse Einkapselung im Bereich der Defekte beobachtet. Im Gegensatz dazu bewirkte die Präsenz einer Membran das Einwachsen von Knochen in die Defekte und der Knochenkontakt an der Implantatbasis wurde gefördert. Die Injektion von Ca-P-Zement resultierte in einer fast kompletten Auffüllung der Defekte um die Implantate. Die Zementoberfläche war völlig mit Knochen bedeckt. Es konnte eine aktive Resorption und eine Remodellierung der Zementpartikel beobachtet werden. Dies lässt ein Muster mit langsamer Resorption assoziiert mit komplettem Ersatz durch neugebildeten Knochen vermuten. Die zusätzliche Verwendung einer Membran brachte keine weiteren Vorteile. Der Knochen-/Implantat-Kontakt an der Implantatbasis war vergleichbar mit den Implantaten, die nur mit einer Membran abgedeckt worden waren. Zusammenfassend kann festgehalten werden, dass der verwendete Ca-P-Zement eine exzellente Handhabung kombiniert mit ausserodentlichem Knochenverhalten zeigte. Andererseits war die Zersetzungsrate des Materials immer noch sehr Gering. Diese momentanen Eigenschaften können letztendlich die klinische Anwendbarkeit des Materials als Defektfüller bei periimplantären und parodontalen Defekten behindern. Resumen La intención del presente estudio fue evaluar la aplicabilidad clínica y el comportamiento biológico de un cemento recientemente desarrollado de fosfato de calcio (Ca-P) como relleno óseo para huecos alrededor de los implantes orales. Se insertaron veinticuatro implantes del tipo escalón creando huecos de 1 y 2 mm en el hueso trabecular de los cóndilos femorales mediales de 6 cabras. Se probaron cuatro situaciones diferentes: 1) implantes + huecos; 2) implantes + huecos, pero cubiertos con una membrana de ácido poliláctico; 3) implantes + huecos que se rellenaron con cemento de Ca-P; y 4) + huecos que se rellenaron con cemento de Ca-P y se cubrieron con una membrana. Todos los implantes se dejaron en su lugar durante 12 semanas. las mediciones histológicas e histomorfométricas cuantitativas demonstraron que los implantes + huecos tuvieron generalmente un contacto óseo pobre en la base del implante. Posteriormente, se observó una encapsulación fibrosa en la parte del hueco. En contraste, la presencia de la membrana promocionó el crecimiento óseo hacia el hueco y también el contacto óseo en la base del implante. La inyección de cemento Ca-P resultó en un casi completo relleno de los huecos alrededor del implante. La superficie del cemento se cubrió completamente de hueso. La reabsorción activa y la remodelación de las partículas de cemento fueron observadas, lo cual sugiere un patrón de reabsorción lenta asociada con una completa sustitución con hueso neoformado. El uso adicional de la membrana no resultó en beneficios adicionales. El contacto hueso implante en la base del implante fue comparable con los implantes que solo tenían la membrana. En conclusión, el uso de cemento de Ca-P mostró excelentes propiedades de manejo clínico combinado con un superior comportamiento óseo. Por otro lado, el índice de degradación del material fue muy lento. Estas características actuales pueden estorbar la aplicabilidad clínica final del material como rellenador de huecos alrededor de defectos periodontales o perimplantarios. [source] The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: Acetic acid versus citric acidJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 1 2008Saeed Hesaraki Abstract In the present study, macroporous calcium phosphate cements (CPCs) were prepared using a porogen; that is, the gas-foaming technique. The objective was to investigate the influence of the acidic component of the porogen (acetic acid versus citric acid) on several properties of a specified CPC. In all of the cements prepared, the basic component of the porogen was the same, namely, NaHCO3, and it was added to the powder phase of the cement, while the acidic component of the porogen was dissolved in the liquid phase of the cement. The cements were characterized in terms of initial setting time, porosity, crystallinity, injectability and compressive strength. Also, XRD, FTIR, and SEM techniques were employed to evaluate the phase composition, the chemical groups and the morphological aspects of the porous cements during setting. It was found that the presence of a porogen in a CPC led to significant decreases in both its initial setting time and compressive strength. A CPC made using acetic acid contained a larger amount of the apatite phase but was significantly less injectable and less porous than when citric acid was used. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008 [source] | |||||||||||||